Market Overview

Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

Share:
Cannabis Countdown: Top 10 Marijuana Stock News Stories Of The Week

Cannabis Countdown: Top 10 Marijuana Stock News Stories of the Week

Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 marijuana stock news stories for the week of September 23rd – 29th, 2019.

Without further ado, let’s get started.

10. 4 Cannabis Stocks Crack the Inaugural TSX30 Top Performers List

Canopy Growth (TSX: WEED) (NYSE: CGC) leads group of pot stocks in the new TSX30 list highlighting the 30 top-performing Canadian stocks.

In addition to Canopy, three other Canadian marijuana stocks made the list with all of them cracking the top ten. Included on the new list was Village Farms (TSX: VFF) (NASDAQ: VFF), Aphria (TSX: APHA) (NYSE: APHA) and Neptune Wellness (TSX: NEPT) (NASDAQ: NEPT).

READ FULL TSX30 NEWS

9. Red White & Bloom to Attend Green Chip Stocks Summit in San Francisco This Weekend

The Green Chip Stocks Summit, founded by investment publishing legend Jeff Siegel, is a yearly event hosted exclusively for the sophisticated paid subscribers of the Green Chip Stocks newsletter.

One of the main attractions of the Green Chip Summit was the investor presentation by Red White & Bloom (CSE: RWB – IPO Soon) CEO Brad Rogers.

READ FULL RWB NEWS

8. Natural Selection in the Marijuana Industry, Only the Strongest Cannabis Stocks Will Survive

The climate of the marijuana industry is ever-changing, forcing cannabis companies to either adapt to the times or get left behind.

Former Canopy Growth (TSX: WEED) (NYSE: CGC) CEO Bruce Linton says marijuana stocks that don’t adapt will die.

READ FULL NATURAL SELECTION ARTICLE

7. MediPharm and TerrAscend Ink $27 Million Private Label Deal

MediPharm Labs (TSX: LABS) (OTCQX: MEDIF) announced the signing of a multi-year supply deal with TerrAscend (CSE: TER) (OTCQX: TRSSF).

Under the terms of the deal, MediPharm will supply TerrAscend over the next two years with approximately $27 million worth of high-quality private label cannabis distillate with a renewal option worth up to $192 million.

READ FULL MEDIPHARM NEWS

6. Aleafia Issues Profitable Q3 2019 Guidance, Cancels Reverse Split

Aleafia Health (TSX: ALEF) (OTCQX: ALEAF) announced the issuance of its Q3 2019 guidance.

The company expects to achieve positive net income in the third quarter or 2019.

READ FULL ALEAFIA HEALTH NEWS

Source: Shutterstock

5. Auxly Closes $123 Million Imperial Brands Investment

Auxly Cannabis (TSXV: XLY) (OTCQX: CBWTF) announced the closing of its previously reported $123 million debenture investment from Imperial Brands. The debenture is convertible into 19.9% ownership in Auxly.

The landmark deal currently sits as one of the largest big tobacco investments in cannabis industry history.

READ FULL AUXLY CANNABIS NEWS

4. GW Pharma Receives EU Approval for CBD-Based Seizure Drug Epidyolex

GW Pharmaceuticals (NASDAQ: GWPH) announced this morning that the European Commission has approved the marketing authorization for the company’s plant-derived CBD-based epilepsy drug Epidyolex.

The company’s milestone drug approval opens the door for GW Pharma to launch Epidyolex throughout Europe.

READ FULL GW PHARMA NEWS

3. U.S. Analyst Initiates Coverage on 8 Cannabis Stocks, Includes Price Targets

U.S. based analyst Bill Kirk of MKM Partners initiated coverage on eight marijuana stocks last Friday.

To go along with his research coverage, the analyst also issued a mix of buy/sell ratings and price targets on Canopy Growth (TSX: WEED) (NYSE: CGC), Aurora Cannabis (TSX: ACB) (NYSE: ABC), Cronos Group (TSX: CRON) (NASDAQ: CRON), Tilray (NASDAQ: TLRY), HEXO Corp. (TSX: HEXO) (NYSE-A: HEXO), Curaleaf Holdings (CSE: CURA) (OTCQX: CURLF), Acreage Holdings (CSE: ACRG.U) (OTCQX: ACRGF) and Constellation Brands (NYSE: STZ).

READ FULL U.S. ANALYST NEWS

2. Cannabis Industry Hopes SAFE Banking Act Will Spark New Wave of Growth

The passage of the SAFE Act would allow cannabis companies to open operational bank accounts and let consumers purchase cannabis products with debit or credit cards.

“It’s a very strange scenario to be in when you’re in a fully fledged state legal industry that doesn’t have access to traditional banking. It’s a rather fundamentally large step in the right direction towards a different future for cannabis legalization,” stated Charlie Bachtell CEO of Cresco Labs (CSE: CL) (OTCQX: CRLBF).

READ FULL SAFE ACT NEWS

1. U.S. Cannabis Stocks Jump Following Yesterday’s Historic Cannabis Banking House Vote

The cannabis industry in the United States made history taking a huge step forward after the U.S. The House of Representatives officially passed the SAFE Banking Act in a 321-103 vote.

The following day these 9 U.S. multi-state operators traded higher in reaction to the historic SAFE Banking Act House vote.

READ FULL SAFE ACT MSO NEWS

Image Sourced from Pixabay

Posted-In: cannabis industry marijuana stocks The Cannabis InvestorCannabis News Markets General

 

Related Articles (ABC + ACRGF)

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!

Cannabis Countdown: Top 10 Marijuana Industry News Stories Of The Week

The Week In Cannabis: SAFE Banking Act Clears House, Australia's Capital Legalizes Recreational Weed And More